Omalizumab as a Provoking Factor for Venous Thromboembolism
A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain. Computed tomography pulmonary angiography showed bila...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AboutScience Srl
2019-07-01
|
| Series: | Drug Target Insights |
| Online Access: | https://doi.org/10.1177/1177392819861987 |